Integrated Behavioral Healthcare for Youth With Type 1 Diabetes

Sponsor
University of Miami (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05915975
Collaborator
(none)
50
1
2
8.9
5.6

Study Details

Study Description

Brief Summary

The purpose of this study is to understand how behavioral health care that is coordinated with diabetes medical care compared with behavioral care that is provided in the community (and therefore not coordinated with diabetes medical care).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Behavioral Care Coordinated with Medical Care Intervention
  • Behavioral: Behavioral Care Not Coordinated with Medical Care Intervention
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Integrated Behavioral Healthcare for Low-Income Ethnic Minority Youth With Type 1 Diabetes
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
May 30, 2024
Anticipated Study Completion Date :
May 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Behavioral Care Coordinated with Medical Care

Participants in this group will work with a study team member for four months to improve your skills to manage diabetes, to strengthen the child-caregiver relationship, and/or to address emotional challenges that your child might be experiencing.

Behavioral: Behavioral Care Coordinated with Medical Care Intervention
Participants will be meeting with a behavioral health provider during their clinic visit. Subsequent visits can be held either via telehealth or in-person. Participants should expect weekly visits during the first two months and less frequent visits (biweekly or monthly) for the last two months. Some sessions that are provided via telehealth might be video recorded and later reviewed to ensure that the program is being delivered as intended.

Active Comparator: Behavioral Care Not Coordinated with Medical Care

Participants will receive the standard of care treatment for four months plus a list of clinics that accept their insurance.

Behavioral: Behavioral Care Not Coordinated with Medical Care Intervention
Participants will meet with a study team member during their in-person visit and will receive a list of clinics that are panelled with their insurance. The participants will be responsible for calling the clinics to set up their appointments. Services might be provided in person or via telehealth based on the participant's preference and the clinics' availability.

Outcome Measures

Primary Outcome Measures

  1. Change in Glycemic Control [Baseline and 4 months]

    Will be measured by glycosylated hemoglobin A1c

Secondary Outcome Measures

  1. Change in Diabetes Self-Management [Baseline and 4 months]

    We will measure Type 1 Diabetes Self-management using the Diabetes Management Questionnaire (DMQ; Score Range: 0-100, higher scores indicate greater adherence to diabetes management).

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Type 1 Diabetes diagnosed for one year or more

  2. Latino or Black ethnicity/race

  3. Speak and read English or Spanish

  4. Eligibility for Medicaid

Exclusion Criteria:
  1. Significant developmental disability

  2. Serious psychiatric disorder

  3. Another serious chronic illness

Contacts and Locations

Locations

Site City State Country Postal Code
1 Univeristy of Miami Miami Florida United States 33136

Sponsors and Collaborators

  • University of Miami

Investigators

  • Principal Investigator: Luiza V Mali, Ph.D., University of Miami

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Luiza Vianna Mali, Assistant Professor of Clinical Pediatrics, University of Miami
ClinicalTrials.gov Identifier:
NCT05915975
Other Study ID Numbers:
  • 20230308
First Posted:
Jun 23, 2023
Last Update Posted:
Jun 23, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 23, 2023